IN-VITRO CHARACTERIZATION OF THE NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONIST SB-209670

被引：0
|
作者：
OHLSTEIN, EH [1 ]
NAMBI, P [1 ]
DOUGLAS, SA [1 ]
BECK, G [1 ]
GLEASON, J [1 ]
RUFFOLO, RR [1 ]
FEUERSTEIN, G [1 ]
ELLIOTT, JD [1 ]
机构：
[1] SMITHKLINE BEECHAM PHARMACEUT,KING OF PRUSSIA,PA 19406
来源：
FASEB JOURNAL | 1994年 / 8卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A803 / A803
页数：1
相关论文
共 50 条
  • [1] IN-VIVO PHARMACOLOGICAL CHARACTERIZATION OF THE NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONIST SB-209670
    DOUGLAS, SA
    EDWARDS, RM
    ELLIOTT, JD
    OHLSTEIN, EH
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (02) : 405 - 413
  • [2] ANTIHYPERTENSIVE ACTIONS OF THE NOVEL NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONIST SB-209670
    DOUGLAS, SA
    GELLAI, M
    EZEKIEL, M
    FEUERSTEIN, GZ
    ELLIOTT, JD
    OHLSTEIN, EH
    HYPERTENSION, 1995, 25 (04) : 818 - 822
  • [3] SB-209670, A RATIONALLY DESIGNED POTENT NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONIST
    OHLSTEIN, EH
    NAMBI, P
    DOUGLAS, SA
    EDWARDS, RM
    GELLAI, M
    LAGO, A
    LEBER, JD
    COUSINS, RD
    GAO, AM
    FRAZEE, JS
    PEISHOFF, CE
    BEAN, JW
    EGGLESTON, DS
    ELSHOURBAGY, NA
    KUMAR, C
    LEE, JA
    YUE, TL
    LOUDEN, C
    BROOKS, DP
    WEINSTOCK, J
    FEUERSTEIN, G
    POSTE, G
    RUFFOLO, RR
    GLEASON, JG
    ELLIOTT, JD
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (17) : 8052 - 8056
  • [4] ANTIHYPERTENSIVE EFFECT IF THE ORALLY EFFECTIVE NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONIST SB-209670
    OHLSTEIN, EH
    GELLAI, M
    FEUERSTEIN, G
    DOUGLAS, SA
    HYPERTENSION, 1994, 24 (03) : 403 - 403
  • [5] BINDING OF THE NONPEPTIDE ANTAGONIST, SB-209670, TO ENDOTHELIN RECEPTORS ON CULTURED NEURONS
    LYSKO, PG
    WEBB, CL
    FEUERSTEIN, G
    PEPTIDES, 1995, 16 (07) : 1279 - 1282
  • [6] NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONISTS .2. PHARMACOLOGICAL CHARACTERIZATION OF SB-209670
    OHLSTEIN, EH
    BECK, GR
    DOUGLAS, SA
    NAMBI, P
    LAGO, MA
    GLEASON, JG
    RUFFOLO, RR
    FEUERSTEIN, G
    ELLIOTT, JD
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 271 (02): : 762 - 768
  • [7] CORONARY VASOCONSTRICTION IN-VITRO IN THE HEARTS OF POLYARTHRITIC RATS - EFFECTIVENESS OF IN-VIVO TREATMENT WITH THE ENDOTHELIN RECEPTOR ANTAGONIST SB-209670
    KLEMM, P
    WARNER, TD
    WILLIS, D
    MOORE, AR
    VANE, JR
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (07) : 1327 - 1328
  • [8] BLOCKADE OF RADIOCONTRAST-INDUCED RENAL VASOCONSTRICTION BY THE ENDOTHELIN RECEPTOR ANTAGONIST, SB-209670
    BROOKS, DP
    DEPALMA, PD
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 918 - 918
  • [9] IDENTIFICATION AND CHARACTERIZATION OF ENDOTHELIN (ET) RECEPTORS USING [H-3] (PLUS-OR-MINUS)-SB-209670, A NOVEL NONPEPTIDE ET RECEPTOR ANTAGONIST
    NAMBI, P
    WU, HL
    PULLEN, M
    SLATER, C
    SAUNDERS, D
    HEYS, R
    LEBER, J
    ELLIOTT, JD
    OHLSTEIN, EH
    BROOKS, DP
    GLEASON, J
    RUFFOLO, RR
    FASEB JOURNAL, 1994, 8 (04): : A102 - A102
  • [10] ANTIHYPERTENSIVE EFFECT OF THE ENDOTHELIN RECEPTOR ANTAGONIST SB-209670 IN CONSCIOUS SPONTANEOUSLY HYPERTENSIVE RATS (SHR)
    ELLIOTT, JD
    EZEKIEL, M
    GELLAI, M
    DOUGLAS, SA
    OHLSTEIN, EH
    FASEB JOURNAL, 1994, 8 (04): : A7 - A7
12345